Biochemistry

About Us

Clinical Biochemistry Laboratory of CMC & H, Ludhiana is a state of art laboratory, catering diagnostic & testing services to its patients. Our laboratory works 24×7 and is installed with fully automated analyzers from companies of international repute.

We provide routine tests for assessment of organ functions round the clock with TAT of 3 hrs from the time the sample is received in the lab. We also perform specialized and disease-specific tests and techniques in-house providing results at a much shorter Turn-Around-Time.

Quality of test results is ensured by a team of well-qualified doctors and trained technicians ensuring quality systems are in place. We are also enrolled with External Quality Assurance Scheme (EQAS) to provide valuable services to our customers.

Quality, accuracy, and reliability are as always – our commitment.

Key Features

Fully Automated Clinical Chemistry Analyzers
ECLIA (Electrochemiluminescence technology for Hormones, Tumor markers, Vitamins, etc.)
ELISA (Enzyme-Linked Immunosorbent Assays) for a range of antibodies
Blot analysis
Indirect immunofluorescence assay (IFA) for ANA (anti-nuclear antibodies)
Immunofixation electrophoresis
Serum and Urine Electrophoresis
Chromatography
Spectrophotometry
HPLC for Glycated Hemoglobin

Quick Facts

Operational 24*7 all year round.

Fully automated analyzers from companies of international repute.

Providing reliable, timely and cost-effective diagnostic services to patients and healthcare providers for benefit of the patient.

Specialized and disease-specific tests and techniques available in-house providing results at a much shorter Turn Around Time (TAT)

Under the supervision of well-trained subject experts.

Our Expertise

Diagnostic and screening tests are available for:

Diseases of kidneys, liver, heart, bone, blood, endocrine and reproductive system
Comprehensive list of tests for bone marrow cancers such as multiple myeloma
Markers for detection of cancers associated with breast, liver, pancreas, bladder and colorectal cancer
Comprehensive list of tests for screening of autoimmune disorders
Screening of drugs of abuse
Monitoring of immunosuppressive, anticancer and antiepileptic drugs.
Screening and monitoring of metabolic disorders, diabetes and thyroid diseases.

Clinical Services

These include:

Line immunoblot assays, ANA-17 for qualitative and reliable differentiation of specific ANA’s (anti-nuclear antibodies)
Indirect immune-florescence assay (IFA) to detect nuclear and/ or cytoplasmic antibodies- the gold standard for identifying and characterizing autoantibodies.
Glycated haemoglobin by High-Performance Liquid Chromatography (HPLC)
ELISA testing for- Anti Phospholipid Antibody, Anti Cardiolipin Antibody, recombinant anti-Tissue Transglutaminase (antibodies to TTG and DGP), cANCA (anti PR3), pANCA (anti-MPO) and ANA
Drug assays- Cyclosporine, Methotrexate, Digoxin, Anti-epileptic drugs viz Phenytoin, Valproate, Carbamazepine
Screening for Drugs of Abuse
A full complement of tests for diagnosis, quantification and characterization of plasma cell dyscrasias viz Serum and Urine Protein Electrophoresis, Immunofixation Electrophoresis, Serum Free Light Chain Kappa and Lambda Assay (from the binding site- recommended by International Myeloma Working Group), Intact immunoglobulin and β2 micro-globulin estimations.
Tumor markers- tPSA, AFP, CEA, CA15.3, CA19.9, CA125, HCG + β subunit
Various hormonal profiles for infertility, PCOD, anemia and adrenal, parathyroid, thyroid and pancreatic dysfunctions
Infection marker- procalcitonin

Whats New

The department of clinical Biochemistry will be shortly introducing antinuclear antibody testing by indirect immunofluorescence (ANA IFA) which is the gold standard for ANA testing. The entire faculty of Biochemistry has undergone vigorous training for the same. This will add to the list of tests already provided by the lab such as ANA ELISA and ANA profile (Line ELISA) providing a complete repertoire of tests for autoimmune diseases. With the introduction of kappa and lambda free light chain, multiple myeloma serum and urine panel has been introduced providing a comprehensive panel for diagnosis and monitoring of myeloma patients.

There are ongoing projects and studies being conducted in the department. Dr. Bharti Uppal has been elected President for the Association of Medical Biochemists of India (AMBI) and gave a presidential oration at Mysore. Dr. Ashish K Joy won a first cash prize in the poster competition at a CME at SGRD Amritsar and also won a travel scholarship to present a poster at Durban, South Africa. Dr. Nandita Maini won third prize in an oral presentation at CARES 2018.